GRIFOLS | GRF - Себестоимость





Себестоимость Изменить Дата
Alcon AG USD 1.18B 26M 2026-03
Almirall EUR 191.5M 2.29M 2025-12
Amadeus IT EUR 589.5M 51.6M 2026-03
Amarin USD 26.05M 1.41M 2025-12
argenx SE USD 121M 28.69M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Bayer EUR 5.23B 731M 2026-03
Cie Automotive EUR 1.21B 19.7M 2025-12
Demant DKK 2.89B 188M 2025-12
Ence Energia y Celulosa EUR 109.33M 21.97M 2025-12
Essilor EUR 6.06B 741M 2025-12
Ferrovial EUR 867M 120M 2025-12
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.43B 248M 2026-03
Genmab DKK 81M 23M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
GRIFOLS EUR 1.08B 214.82M 2026-03
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Inditex EUR 6.19B 1.67B 2025-12
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Merck EUR 2.07B 219M 2026-03
Novartis USD 3.46B 83M 2026-03
Philips EUR 2.14B 669M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
Smith & Nephew USD 870M 17M 2025-12
UCB EUR 1.07B 146M 2025-12
Viscofan EUR 192.48M 10.12M 2026-03